Bill > SB1156

This bill establishes new regulations for insulin drug coverage in health insurance plans in Missouri, specifically capping the monthly out-of-pocket cost for prescription insulin drugs at $30 per 30-day supply for enrollees. The bill defines several key terms, including "prescription insulin drug" as an insulin medication used to control blood glucose for diabetes treatment (excluding intravenous insulin), and requires health carriers to calculate an enrollee's cost-sharing at the point of sale by reducing the drug price by at least 100% of all applicable rebates. The legislation protects rebate information as a trade secret and prohibits its public disclosure, while allowing health carriers to further reduce an individual's cost-sharing if desired. The new regulations will apply to health benefit plans delivered, issued, continued, or renewed on or after January 1, 2027, and include a severability clause ensuring that if any part of the law is found invalid, the remainder of the section remains in effect. The bill aims to make insulin more affordable for people with diabetes by limiting their monthly out-of-pocket expenses.

Business and Industry

https://www.senate.mo.gov/26info/BTS_Web/Bill.aspx?SessionType=R&BillID=529